Nyxoah Reports Third Quarter Financial and Operating Results
Nyxoah SA - Ordinary Shares (NYXH)
Company Research
Source: GlobeNewswire
REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating ResultsFDA approval on track for first quarter 2025, U.S. commercial team build out in progressCompany fully funded with cash until mid 2026 Mont-Saint-Guibert, Belgium – November 6, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today reported financial and operating results for the third quarter of 2024. Recent Financial and Operating Highlights Presented compelling DREAM data results at International Surgical Sleep Society in September.Raised €24.6 million through an ATM program from a single U.S. healthcare-dedicated fund providing incremental flexibility as we shift into U.S. commercialization and extending cash runway until mid 2026.Strengthened U.S. organization with the hiring of John Land
Show less
Read more
Impact Snapshot
Event Time:
NYXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYXH alerts
High impacting Nyxoah SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
NYXH
News
- Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswire
- Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024GlobeNewswire
- Publication relating to transparency notificationsGlobeNewswire
- Nyxoah SA (NYXH) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]Yahoo! Finance
- Nyxoah S.A. (NASDAQ: NYXH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $16.00 price target on the stock.MarketBeat
NYXH
Earnings
- 11/6/24 - Miss
NYXH
Sec Filings
- 11/20/24 - Form 6-K
- 11/18/24 - Form 6-K
- 11/8/24 - Form S-8
- NYXH's page on the SEC website